[1]
Sacha , T. 2013. Superior efficacy of nilotinib vs imatinib in patients with chronic myeloid leukemia in chronic phase. ENESTnd and ENESTcmr current results analysis. OncoReview. 3, 1(9) (Mar. 2013), 37-45.